These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 18652687
1. Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer. Heinonen H, Nieminen A, Saarela M, Kallioniemi A, Klefström J, Hautaniemi S, Monni O. BMC Genomics; 2008 Jul 24; 9():348. PubMed ID: 18652687 [Abstract] [Full Text] [Related]
2. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy. Zhao MY, Auerbach A, D'Costa AM, Rapoport AP, Burger AM, Sausville EA, Stass SA, Jiang F, Sands AM, Aguilera N, Zhao XF. Clin Cancer Res; 2009 Mar 01; 15(5):1708-20. PubMed ID: 19223503 [Abstract] [Full Text] [Related]
3. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L, Claret FX, Rassidakis GZ. Cancer Res; 2006 Jul 01; 66(13):6589-97. PubMed ID: 16818631 [Abstract] [Full Text] [Related]
11. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, Adachi Y, Takeuchi T, Koeffler HP, Taguchi H. Leuk Res; 2007 May 01; 31(5):673-82. PubMed ID: 17007924 [Abstract] [Full Text] [Related]
12. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer. Chen X, Zhao M, Hao M, Sun X, Wang J, Mao Y, Zu L, Liu J, Shen Y, Wang J, Shen K. Mol Cancer Res; 2013 Oct 01; 11(10):1269-78. PubMed ID: 23814023 [Abstract] [Full Text] [Related]
13. Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway. DeGraffenried LA, Fulcher L, Friedrichs WE, Grünwald V, Ray RB, Hidalgo M. Ann Oncol; 2004 Oct 01; 15(10):1510-6. PubMed ID: 15367412 [Abstract] [Full Text] [Related]
15. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition. Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, Coram MA, Piskun CM, Longacre TA, Herrler M, Frimannsson DO, Telli ML, Dirbas FM, Matin AC, Dairkee SH, Larijani B, Glinsky GV, Bild AH, Jeffrey SS. Breast Cancer Res; 2014 Apr 07; 16(2):R36. PubMed ID: 24708766 [Abstract] [Full Text] [Related]
16. Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis. Ung MH, Wang GL, Varn FS, Cheng C. Oncotarget; 2016 Dec 20; 7(51):84142-84154. PubMed ID: 27589846 [Abstract] [Full Text] [Related]
18. AMPK/mTOR/p70S6K axis prevents apoptosis of Porphyromonas gingivalis-infected gingival epithelial cells via BadSer136 phosphorylation. Wang Y, Dong Y, Zhang W, Wang Y, Jao Y, Liu J, Zhang M, He H. Apoptosis; 2023 Aug 20; 28(7-8):1012-1023. PubMed ID: 37014579 [Abstract] [Full Text] [Related]
19. The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation. Gäbele E, Reif S, Tsukada S, Bataller R, Yata Y, Morris T, Schrum LW, Brenner DA, Rippe RA. J Biol Chem; 2005 Apr 08; 280(14):13374-82. PubMed ID: 15677443 [Abstract] [Full Text] [Related]
20. Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling. Nakao T, Shiota M, Tatemoto Y, Izumi Y, Iwao H. J Pharmacol Sci; 2007 Dec 08; 105(4):334-41. PubMed ID: 18057776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]